Cardiovascular Pulmonary Research Laboratory, University of Colorado Denver, Aurora, CO 80045, USA.
Am J Respir Crit Care Med. 2011 Feb 1;183(3):330-40. doi: 10.1164/rccm.201002-0154OC. Epub 2010 Sep 2.
Studies with genetically engineered mice showed that decreased expression of the transmembrane peptidase neprilysin (NEP) increases susceptibility to hypoxic pulmonary vascular remodeling and hypertension; in hypoxic wild-type mice, expression is decreased early in distal pulmonary arteries, where prominent vascular remodeling occurs. Therefore, in humans with smoke- and hypoxia-induced vascular remodeling, as in chronic obstructive pulmonary disease (COPD), pulmonary activity/expression of NEP may likewise be decreased.
To test whether NEP activity and expression are reduced in COPD lungs and pulmonary arterial smooth muscle cells (SMCs) exposed to cigarette smoke extract or hypoxia and begin to investigate mechanisms involved.
Control and advanced COPD lung lysates (n = 13-14) were analyzed for NEP activity and protein and mRNA expression. As a control, dipeptidyl peptidase IV activity was analyzed. Lung sections were assessed for vascular remodeling and oxidant damage. Human pulmonary arterial SMCs were exposed to cigarette smoke extract, hypoxia, or H₂O₂, and incubated with antioxidants or lysosomal/proteasomal inhibitors.
COPD lungs demonstrated areas of vascular rarification, distal muscularization, and variable intimal and prominent medial/adventitial thickening. NEP activity was reduced by 76%; NEP protein expression was decreased in alveolar walls and distal vessels; mRNA expression was also decreased. In SMCs exposed to cigarette smoke extract, hypoxia, and H₂O₂, NEP activity and expression were also reduced. Reactive oxygen species inactivated NEP activity; NEP protein degradation appeared to be substantially induced.
Mechanisms responsible for reduced NEP activity and protein expression include oxidative reactions and protein degradation. Maintaining or increasing lung NEP may protect against pulmonary vascular remodeling in response to chronic smoke and hypoxia.
基因工程小鼠研究表明,跨膜肽酶 Neprilysin(NEP)表达降低会增加低氧性肺血管重构和高血压的易感性;在低氧野生型小鼠中,表达在远端肺动脉中早期降低,而此处会发生明显的血管重构。因此,在慢性阻塞性肺疾病(COPD)等因吸烟和缺氧引起血管重构的人群中,NEP 的肺活性/表达可能也会降低。
检测 COPD 肺组织和暴露于香烟烟雾提取物或低氧环境中的肺动脉平滑肌细胞(SMC)中 NEP 活性和表达是否降低,并开始探究相关机制。
分析对照和晚期 COPD 肺组织裂解物(n = 13-14)中的 NEP 活性和蛋白及 mRNA 表达情况。作为对照,分析二肽基肽酶 IV 活性。评估肺组织切片的血管重构和氧化损伤情况。将人肺动脉 SMC 暴露于香烟烟雾提取物、低氧或 H₂O₂中,并与抗氧化剂或溶酶体/蛋白酶体抑制剂孵育。
COPD 肺组织表现出血管稀疏、远端肌化以及可变内膜和明显中膜/外膜增厚。NEP 活性降低了 76%;肺泡壁和远端血管中 NEP 蛋白表达减少;mRNA 表达也降低。在暴露于香烟烟雾提取物、低氧和 H₂O₂的 SMC 中,NEP 活性和表达也降低。活性氧使 NEP 活性失活;NEP 蛋白降解似乎明显被诱导。
导致 NEP 活性和蛋白表达降低的机制包括氧化反应和蛋白降解。维持或增加肺 NEP 可能有助于防止慢性吸烟和缺氧引起的肺血管重构。